SAMITAL® improves chemo/radiotherapy-induced oral mucositis in patients with head and neck cancer: Results of a randomized, placebo-controlled, single-blind Phase II study

Supportive Care in Cancer

Volumn 21, Issue 3, 2013, Pages 827-834

  Pawar, D ^a   Neve, R S ^b   Kalgane, S ^b   Riva, A ^c   Bombardelli, E ^c   Ronchi, M ^c   Petrangolini, G ^c   Morazzoni, P ^c  

^a Drug Research Laboratory   (India)

^b Ruby Hall Clinic   (India)

^c INDENA S P A   (Italy)

Author keywords

Chemotherapy; Head and neck cancer; Oral mucositis; Radiotherapy; SAMITAL

Indexed keywords

CISPLATIN; ECHINACEA ANGUSTIFOLIA EXTRACT; MACLEAYA CORDATA EXTRACT; PLACEBO; PLANT EXTRACT; SAMITAL; UNCLASSIFIED DRUG; VACCINIUM MYRTILLUS EXTRACT;

ABSENCE OF SIDE EFFECTS; ADULT; ANALGESIA; ARTICLE; CANCER RADIOTHERAPY; CLINICAL ARTICLE; CONTROLLED STUDY; DAILY LIFE ACTIVITY; DISEASE SEVERITY; DRUG ABSORPTION; DRUG BLOOD LEVEL; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; ECHINACEA ANGUSTIFOLIA; FEMALE; FLUID INTAKE; FOOD INTAKE; FRUIT; HEAD AND NECK CANCER; HUMAN; MACLEAYA CORDATA; MALE; MEDICINAL PLANT; MULTIPLE CYCLE TREATMENT; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; ORAL MUCOSITIS; PATIENT COMPLIANCE; PHASE 2 CLINICAL TRIAL; PLANT ROOT; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; SINGLE BLIND PROCEDURE; SLEEP; TREATMENT OUTCOME; VACCINIUM MYRTILLUS; VISUAL ANALOG SCALE; WHO SEVERITY SCALE;

ADULT; AGED; CHEMORADIOTHERAPY; FEMALE; HEAD AND NECK NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PAIN; PLANT EXTRACTS; QUALITY OF LIFE; SEVERITY OF ILLNESS INDEX; SINGLE-BLIND METHOD; STOMATITIS; TREATMENT OUTCOME;

EID: 84874107886     PISSN: 09414355     EISSN: 14337339     Source Type: Journal    
DOI: 10.1007/s00520-012-1586-5     Document Type: Article

References (23)

1. Peterson DE, Bensadoun RJ et al (2010) Management of oral and gastrointestinal mucositis: ESMO Clinical Practice Guidelines. Annals of Oncology 21(Suppl 5):v261-v265
2. Trotti A, Bellm LA, Epstein JB, Frame D, Fuchs HJ, Gwede CK, Komaroff E, Nalysnyk L, Zilberberg MD (2003) Mucositis incidence, severity and associated outcomes in patients with head and neck cancer receiving radiotherapy with or without chemotherapy: a systematic literature review. Radiother Oncol 66(3):253-262
3. Trotti A, Garden A, Warde P, Symonds P, Langer C, Redman R et al (2004) A multinational, randomized Phase III trial of iseganan HCl oral solution for reducing the severity of oral mucositis in patients receiving radiotherapy for head-and-neck malignancy. Int J Radiation Oncology Biol Phys 58:674-681
4. Sonis ST (2009) Mucositis: the impact, biology and therapeutic opportunities of oral mucositis. Oral Oncol 45(12):1015-1020
5. Sonis ST (2007) Pathobiology of oral mucositis: novel insights and opportunities. J Support Oncol 5(9 suppl 4):3-11
6. Morazzoni P, Bombardelli E (1996) Vaccinium myrtillus L. Fitoterapia 67:1-28
7. Mackraj I, Govender T, Gathiram P (2008) Sanguinarine. Cardiovasc Ther 26:75-83
8. Fadeeva NI, Degtyariova IN, Gerasina SF, et al. (1987) Research of the mechanism of action of sanguiritrin conducted on some biochemical models. Vilar (Russion Institute of Medicinal and Aromatic Plants, Mosca). Unpublished data
9. Godowski KC (1989) Antimicrobial action of sanguinarine. J Clin Dent 1(4):96-101
10. Frankos VH, Brusick DJ, Johnson EM, Maibach HI, Munro I, Squire RA, Weil CS (1990) Safety of Sanguinaria extract as used in commercial toothpaste and oral rinse products. J Clin Dent 56(7 Suppl):41-47
11. Kopczyk RA, Abrams H, Brown AT, Matheny JL, Kaplan AL (1991) Clinical and microbiological effects of a sanguinaria-containing mouthrinse and dentifrice with and without fluoride during 6 months of use. J Periodontol 62(10):617-622
12. Chaturvedi MM, Kumar A, Darnay BG et al (1997) Sanguinarine (pseudochelerythrine) is a potent inhibitor of NF-κB activation, IκBα phosphorylation, and degradation. J Biol Chem 272:30129-30134
13. Raduner S, Majewska A, Chen JZ, Xie XQ, Hamon J, Faller B et al (2006) Alkylamides from Echinacea are a new class of cannabinomimetics. J Biol Chem 281(20):14192-14206
14. Guindon J, Hohmann AG (2008) Cannabinoid CB2 receptors: a therapeutic target for the treatment of inflammatory and neuropathic pain. Br J Pharm 153:319-334
15. Birt DF, Widrlechner MP et al (2008) Echinacea in infection. Am J Clin Nutr 87(2):488S-492S
16. Sonis ST (2004) The pathobiology of mucositis. Nat Rev Cancer 4(4):277-284
17. Stiff PJ, Erder H, Bensinger WI, Emmanouilides C, Gentile T, Isitt J et al (2006) Reliability and validity of a patient self-administered daily questionnaire to assess impact of oral mucositis (OM) on pain and daily functioning in patients undergoing autologous hematopoietic stem cell transplantation (HSCT). Bone Marrow Transplant 37:392-401
18. Zhang XX, Ma L, Wang JL, Wu WM, Feng LC, Huang DL (2011) Management of oral mucositis in patients with head and neck cancer receiving chemoradiotherapy and/or molecular targeted therapy. Zhonghua Er Bi Yan Hou Tou Jing Wai Ke Za Zhi 46(6):505-508
19. Pawar D, Banavalikar M, Riva A, Bombardelli E, Petrangolini G, Morazzoni P (2011) Development and validation of an HPLC/MS/MS method for the quantitative determination of sanguinarine and its major metabolite dihydrosanguinarine in human plasma. Presented as a poster at the 40th ACCP Annual Meeting, September 2011
20. Federal Register (2003) 21 CFR Part 356 oral health care drug products for over-the- counter human use; antigingivitis/antiplaque drug products; establishment of a monograph; proposed rules; 68 FR 32231
21. Turner JA, Deyo RA, Loeser JD, Von Korff M, Fordyce WE et al (1995) The importance of placebo effect in pain treatment and research. JAMA 273(4):283
22. Rubenstein EB, Peterson DE, Schubert M et al (2004) Clinical practice guidelines for the prevention and treatment of cancer therapy-induced oral and gastrointestinal mucositis. Cancer 100(9 Suppl):2026-2046
23. Giacosa A, Pawar D, Bertoglio JC, Bombardelli E, Morazzoni P, Ronchi M, Petrangolini G, Riva A (2011) SAMITAL®: a new challenge for the treatment of oral mucositis induced by chemo/radiotherapy. Eur J Cancer 47(suppl 1):S242